
Nearly a dozen countries resume AstraZeneca shots after EU regulator say benefits outweigh risks
Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said the benefits outweighed any risks after reports of rare instances of ...